top of page
Search

BioAccess Podcast - Justin Chickles, CEO & Co-Founder of Glycyx Therapeutics

  • Justin Chickles
  • Sep 1, 2025
  • 1 min read

Could opioids be silently undermining cancer immunotherapy?


This week, Justin Chickles — CEO and co-founder of Glycyx Therapeutics — explains how his team is tackling this overlooked challenge with axelopran, a breakthrough therapy now advancing to Phase 2 trials.


 
 
 

©2025 by Glycyx Therapeutics

bottom of page